{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:26:30Z","timestamp":1780460790187,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12967-014-0327-6","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T18:41:33Z","timestamp":1418150493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Differential hypoglycaemic, anorectic, autonomic and emetic effects of the glucagon-like peptide receptor agonist, exendin-4, in the conscious telemetered ferret"],"prefix":"10.1186","volume":"12","author":[{"given":"Zengbing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Percie Du Sert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Wa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Kong","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David TW","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul LR","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"327_CR1","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","volume":"2","author":"B Kreymann","year":"1987","unstructured":"Kreymann B, Williams G, Ghatei MA, Bloom SR: Glucagon-like peptide-1 7\u201336: a physiological incretin in man. Lancet. 1987, 2: 1300-1304. 10.1016\/S0140-6736(87)91194-9.","journal-title":"Lancet"},{"key":"327_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1124\/pr.55.1.6","volume":"55","author":"KE Mayo","year":"2003","unstructured":"Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, Drucker DJ: International union of pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003, 55: 167-194. 10.1124\/pr.55.1.6.","journal-title":"Pharmacol Rev"},{"key":"327_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2337\/diabetes.49.4.611","volume":"49","author":"A Vella","year":"2000","unstructured":"Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA: Effect of glucagon-like peptide 1(7\u201336) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes. 2000, 49: 611-617. 10.2337\/diabetes.49.4.611.","journal-title":"Diabetes"},{"key":"327_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/dmrr.357","volume":"19","author":"JM Egan","year":"2003","unstructured":"Egan JM, Bulotta A, Hui H, Perfetti R: GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. Diabetes Metab Res Rev. 2003, 19: 115-123. 10.1002\/dmrr.357.","journal-title":"Diabetes Metab Res Rev"},{"key":"327_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/BF01316798","volume":"38","author":"A Wettergren","year":"1993","unstructured":"Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ: Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci. 1993, 38: 665-673. 10.1007\/BF01316798.","journal-title":"Dig Dis Sci"},{"key":"327_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1172\/JCI942","volume":"102","author":"T Tolessa","year":"1998","unstructured":"Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM: Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest. 1998, 102: 764-774. 10.1172\/JCI942.","journal-title":"J Clin Invest"},{"key":"327_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.physbeh.2004.04.019","volume":"82","author":"JP Gutzwiller","year":"2004","unstructured":"Gutzwiller JP, Degen L, Heuss L, Beglinger C: Glucagon-like peptide 1 (GLP-1) and eating. Physiol Behav. 2004, 82: 17-19. 10.1016\/j.physbeh.2004.04.019.","journal-title":"Physiol Behav"},{"key":"327_CR8","doi-asserted-by":"publisher","first-page":"R562","DOI":"10.1152\/ajpregu.00599.2003","volume":"287","author":"JP Gutzwiller","year":"2004","unstructured":"Gutzwiller JP, Degen L, Matzinger D, Prestin S, Beglinger C: Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men. Am J Physiol Regul Integr Comp Physiol. 2004, 287: R562-R567. 10.1152\/ajpregu.00599.2003.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"327_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1358\/dot.2005.41.9.893704","volume":"41","author":"AH Barnett","year":"2005","unstructured":"Barnett AH: Exenatide. Drugs Today (Barc). 2005, 41: 563-578. 10.1358\/dot.2005.41.9.893704.","journal-title":"Drugs Today (Barc)"},{"key":"327_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.clinthera.2006.05.006","volume":"28","author":"JL Iltz","year":"2006","unstructured":"Iltz JL, Baker DE, Setter SM, Keith Campbell R: Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus. Clin Ther. 2006, 28: 652-665. 10.1016\/j.clinthera.2006.05.006.","journal-title":"Clin Ther"},{"key":"327_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0165-6147(03)00160-3","volume":"24","author":"T Perry","year":"2003","unstructured":"Perry T, Greig NH: The glucagon-like peptides: a double-edged therapeutic sword?. Trends Pharmacol Sci. 2003, 24: 377-383. 10.1016\/S0165-6147(03)00160-3.","journal-title":"Trends Pharmacol Sci"},{"key":"327_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1463-1326.2011.01357.x","volume":"13","author":"S Madsbad","year":"2011","unstructured":"Madsbad S, Kielgast U, Asmar M, Deacon CF, Torekov SS, Holst JJ: An overview of once-weekly glucagon-like peptide-1 receptor agonists\u2013available efficacy and safety data and perspectives for the future. Diabetes Obes Metab. 2011, 13: 394-407. 10.1111\/j.1463-1326.2011.01357.x.","journal-title":"Diabetes Obes Metab"},{"key":"327_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1476-5381.2009.00176.x","volume":"157","author":"AM Holmes","year":"2009","unstructured":"Holmes AM, Rudd JA, Tattersall FD, Aziz Q, Andrews PL: Opportunities for the replacement of animals in the study of nausea and vomiting. Br J Pharmacol. 2009, 157: 865-880. 10.1111\/j.1476-5381.2009.00176.x.","journal-title":"Br J Pharmacol"},{"key":"327_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.tips.2011.03.009","volume":"32","author":"GJ Sanger","year":"2011","unstructured":"Sanger GJ, Holbrook JD, Andrews PL: The translational value of rodent gastrointestinal functions: a cautionary tale. Trends Pharmacol Sci. 2011, 32: 402-409. 10.1016\/j.tips.2011.03.009.","journal-title":"Trends Pharmacol Sci"},{"key":"327_CR15","doi-asserted-by":"crossref","unstructured":"Horn CC, Kimball BA, Wang H, Kaus J, Dienel S, Nagy A, Gathright GR, Yates BJ, Andrews PL: Why can\u2019t rodents vomit? A comparative behavioral, anatomical, and physiological study.PLoS One 2013, 8:e60537.,","DOI":"10.1371\/journal.pone.0060537"},{"key":"327_CR16","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1023\/A:1026678925120","volume":"43","author":"T Tolessa","year":"1998","unstructured":"Tolessa T, Gutniak M, Holst JJ, Efendic S, Hellstrom PM: Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms. Dig Dis Sci. 1998, 43: 2284-2290. 10.1023\/A:1026678925120.","journal-title":"Dig Dis Sci"},{"key":"327_CR17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.coph.2006.08.003","volume":"6","author":"MM Combettes","year":"2006","unstructured":"Combettes MM: GLP-1 and type 2 diabetes: physiology and new clinical advances. Curr Opin Pharmacol. 2006, 6: 598-605. 10.1016\/j.coph.2006.08.003.","journal-title":"Curr Opin Pharmacol"},{"key":"327_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejphar.2007.03.050","volume":"566","author":"SW Chan","year":"2007","unstructured":"Chan SW, He J, Lin G, Rudd JA, Yamamoto K: Action of GLP-1 (7\u201336) amide and exendin-4 on Suncus murinus (house musk shrew) isolated ileum. Eur J Pharmacol. 2007, 566: 185-191. 10.1016\/j.ejphar.2007.03.050.","journal-title":"Eur J Pharmacol"},{"key":"327_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ejphar.2011.06.036","volume":"668","author":"SW Chan","year":"2011","unstructured":"Chan SW, Lin G, Yew DT, Rudd JA: A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew). Eur J Pharmacol. 2011, 668: 340-346. 10.1016\/j.ejphar.2011.06.036.","journal-title":"Eur J Pharmacol"},{"key":"327_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuropharm.2013.01.013","volume":"70","author":"SW Chan","year":"2013","unstructured":"Chan SW, Lin G, Yew DT, Yeung CK, Rudd JA: Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew). Neuropharmacology. 2013, 70: 141-147. 10.1016\/j.neuropharm.2013.01.013.","journal-title":"Neuropharmacology"},{"key":"327_CR21","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1111\/j.1476-5381.2011.01669.x","volume":"165","author":"N Percie Du Sert","year":"2012","unstructured":"Percie Du Sert N, Holmes AM, Wallis R, Andrews PL: Predicting the emetic liability of novel chemical entities: a comparative study. Br J Pharmacol. 2012, 165: 1848-1867. 10.1111\/j.1476-5381.2011.01669.x.","journal-title":"Br J Pharmacol"},{"key":"327_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/9781118782699.ch31","volume-title":"Biology and Diseases of the Ferret","author":"N Percie du Sert","year":"2014","unstructured":"Percie du Sert N, Andrews PLR: The ferret in nausea and vomiting research: lessons in translation of basic science to the clinic. Biology and Diseases of the Ferret. 2014, John Wiley & Sons, Inc, New Jersey, 735-778. 10.1002\/9781118782699.ch31."},{"key":"327_CR23","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","volume":"268","author":"R Goke","year":"1993","unstructured":"Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B: Exendin-4 is a high potency agonist and truncated exendin-(9\u201339)-amide an antagonist at the glucagon-like peptide 1-(7\u201336)-amide receptor of insulin-secreting beta-cells. J Biol Chem. 1993, 268: 19650-19655.","journal-title":"J Biol Chem"},{"key":"327_CR24","volume-title":"Nausea: Mechanisms and Management","author":"RM Stern","year":"2011","unstructured":"Stern RM, Koch KL, Andrews PLR: Nausea: Mechanisms and Management. 2011, Oxford University Press, Oxford"},{"key":"327_CR25","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.3748\/wjg.15.6034","volume":"15","author":"N Percie Du Sert","year":"2009","unstructured":"Percie Du Sert N, Chu KM, Wai MK, Rudd JA, Andrews PL: Reduced normogastric electrical activity associated with emesis: a telemetric study in ferrets. World J Gastroenterol. 2009, 15: 6034-6043. 10.3748\/wjg.15.6034.","journal-title":"World J Gastroenterol"},{"key":"327_CR26","first-page":"2825","volume":"2011","author":"J Kim","year":"2011","unstructured":"Kim J, Napadow V, Kuo B, Barbieri R: A combined HRV-fMRI approach to assess cortical control of cardiovagal modulation by motion sickness. Conf Proc IEEE Eng Med Biol Soc. 2011, 2011: 2825-2828.","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"327_CR27","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1007\/s00221-014-3964-3","volume":"232","author":"AD Farmer","year":"2014","unstructured":"Farmer AD, Al Omran Y, Aziz Q, Andrews PL: The role of the parasympathetic nervous system in visually induced motion sickness: systematic review and meta-analysis. Exp Brain Res. 2014, 232: 2665-2673. 10.1007\/s00221-014-3964-3.","journal-title":"Exp Brain Res"},{"key":"327_CR28","first-page":"71","volume-title":"The Biology and Diseases of the Ferrets","author":"INC Lawes","year":"1998","unstructured":"Lawes INC, Andrews PLR: Neuroanatomy of the ferret brain. The Biology and Diseases of the Ferrets. 1998, Williams & Wilkins, Co, Baltimore, 71-102. 2","edition":"2"},{"key":"327_CR29","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/hep.23569","volume":"51","author":"NA Gupta","year":"2010","unstructured":"Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, Saxena NK, Anania FA: Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology. 2010, 51: 1584-1592. 10.1002\/hep.23569.","journal-title":"Hepatology"},{"key":"327_CR30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-3565(24)34872-4","volume":"290","author":"K Venkova","year":"1999","unstructured":"Venkova K, Palmer JM, Greenwood-Van Meerveld B: Nematode-induced jejunal inflammation in the ferret causes long-term changes in excitatory neuromuscular responses. J Pharmacol Exp Ther. 1999, 290: 96-103.","journal-title":"J Pharmacol Exp Ther"},{"key":"327_CR31","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1161\/STROKEAHA.107.510677","volume":"39","author":"L Zheng","year":"2008","unstructured":"Zheng L, Sun Z, Li J, Zhang R, Zhang X, Liu S, Li J, Xu C, Hu D, Sun Y: Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China. Stroke. 2008, 39: 1932-1937. 10.1161\/STROKEAHA.107.510677.","journal-title":"Stroke"},{"key":"327_CR32","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/j.1540-8159.1996.tb03185.x","volume":"19","author":"M Reardon","year":"1996","unstructured":"Reardon M, Hnatkova K, Malik M: Aging and time-domain and spectral turbulence parameters of signal-averaged electrocardiograms. Pacing Clin Electrophysiol. 1996, 19: 1588-1594. 10.1111\/j.1540-8159.1996.tb03185.x.","journal-title":"Pacing Clin Electrophysiol"},{"key":"327_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s001250051111","volume":"42","author":"NH Greig","year":"1999","unstructured":"Greig NH, Holloway HW, De Ore KA, Jani D, Wang Y, Zhou J, Garant MJ, Egan JM: Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations. Diabetologia. 1999, 42: 45-50. 10.1007\/s001250051111.","journal-title":"Diabetologia"},{"key":"327_CR34","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.2337\/diabetes.50.7.1562","volume":"50","author":"C Tourrel","year":"2001","unstructured":"Tourrel C, Bailbe D, Meile MJ, Kergoat M, Portha B: Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes. 2001, 50: 1562-1570. 10.2337\/diabetes.50.7.1562.","journal-title":"Diabetes"},{"key":"327_CR35","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1152\/ajpendo.2001.281.1.E155","volume":"281","author":"CM Edwards","year":"2001","unstructured":"Edwards CM, Stanley SA, Davis R, Brynes AE, Frost GS, Seal LJ, Ghatei MA, Bloom SR: Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab. 2001, 281: E155-E161.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"327_CR36","doi-asserted-by":"publisher","first-page":"25786","DOI":"10.1074\/jbc.M804372200","volume":"283","author":"DD De Leon","year":"2008","unstructured":"De Leon DD, Li C, Delson MI, Matschinsky FM, Stanley CA, Stoffers DA: Exendin-(9\u201339) corrects fasting hypoglycemia in SUR-1\u2212\/\u2212 mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion. J Biol Chem. 2008, 283: 25786-25793. 10.1074\/jbc.M804372200.","journal-title":"J Biol Chem"},{"key":"327_CR37","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/dom.12108","volume":"15","author":"A Flint","year":"2013","unstructured":"Flint A, Kapitza C, Zdravkovic M: The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment. Diabetes Obes Metab. 2013, 15: 958-962. 10.1111\/dom.12108.","journal-title":"Diabetes Obes Metab"},{"key":"327_CR38","doi-asserted-by":"publisher","first-page":"16199","DOI":"10.1073\/pnas.1306799110","volume":"110","author":"R Shirazi","year":"2013","unstructured":"Shirazi R, Palsdottir V, Collander J, Anesten F, Vogel H, Langlet F, Jaschke A, Schurmann A, Prevot V, Shao R, Jansson JO, Skibicka KP: Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6. Proc Natl Acad Sci U S A. 2013, 110: 16199-16204. 10.1073\/pnas.1306799110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"327_CR39","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-13-0414","volume":"221","author":"L Van Bloemendaal","year":"2013","unstructured":"Van Bloemendaal L, Ten Kulve JS, La Fleur SE, Ijzerman RG, Diamant M: Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol. 2013, 221: T1-T16. 10.1530\/JOE-13-0414.","journal-title":"J Endocrinol"},{"key":"327_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.peptides.2010.09.028","volume":"32","author":"A Rotondo","year":"2011","unstructured":"Rotondo A, Amato A, Lentini L, Baldassano S, Mule F: Glucagon-like peptide-1 relaxes gastric antrum through nitric oxide in mice. Peptides. 2011, 32: 60-64. 10.1016\/j.peptides.2010.09.028.","journal-title":"Peptides"},{"key":"327_CR41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1365-2982.2010.01476.x","volume":"22","author":"A Amato","year":"2010","unstructured":"Amato A, Cinci L, Rotondo A, Serio R, Faussone-Pellegrini MS, Vannucchi MG, Mule F: Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors. Neurogastroenterol Motil. 2010, 22: 664-e203. 10.1111\/j.1365-2982.2010.01476.x.","journal-title":"Neurogastroenterol Motil"},{"key":"327_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2982.2004.00628.x","volume":"17","author":"SE Ayachi","year":"2005","unstructured":"Ayachi SE, Borie F, Magous R, Sasaki K, Le Nguyen D, Bali JP, Millat B, Jarrousse C: Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9\u201339). Neurogastroenterol Motil. 2005, 17: 302-309. 10.1111\/j.1365-2982.2004.00628.x.","journal-title":"Neurogastroenterol Motil"},{"key":"327_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0014-5793(94)01430-9","volume":"358","author":"Y Wei","year":"1995","unstructured":"Wei Y, Mojsov S: Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett. 1995, 358: 219-224. 10.1016\/0014-5793(94)01430-9.","journal-title":"FEBS Lett"},{"key":"327_CR44","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/endo.137.7.8770921","volume":"137","author":"BP Bullock","year":"1996","unstructured":"Bullock BP, Heller RS, Habener JF: Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology. 1996, 137: 2968-2978.","journal-title":"Endocrinology"},{"key":"327_CR45","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1111\/j.1460-9568.1995.tb00650.x","volume":"7","author":"R Goke","year":"1995","unstructured":"Goke R, Larsen PJ, Mikkelsen JD, Sheikh SP: Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci. 1995, 7: 2294-2300. 10.1111\/j.1460-9568.1995.tb00650.x.","journal-title":"Eur J Neurosci"},{"key":"327_CR46","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1210\/endo.137.11.8895391","volume":"137","author":"PJ Shughrue","year":"1996","unstructured":"Shughrue PJ, Lane MV, Merchenthaler I: Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology. 1996, 137: 5159-5162.","journal-title":"Endocrinology"},{"key":"327_CR47","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.2337\/diabetes.53.9.2492","volume":"53","author":"LL Baggio","year":"2004","unstructured":"Baggio LL, Huang Q, Brown TJ, Drucker DJ: A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes. 2004, 53: 2492-2500. 10.2337\/diabetes.53.9.2492.","journal-title":"Diabetes"},{"key":"327_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","volume":"1044","author":"CR Abbott","year":"2005","unstructured":"Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, Bloom SR: The inhibitory effects of peripheral administration of peptide YY(3\u201336) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005, 1044: 127-131. 10.1016\/j.brainres.2005.03.011.","journal-title":"Brain Res"},{"key":"327_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/gut.44.1.81","volume":"44","author":"JP Gutzwiller","year":"1999","unstructured":"Gutzwiller JP, Goke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, Winterhalder R, Conen D, Beglinger C: Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut. 1999, 44: 81-86. 10.1136\/gut.44.1.81.","journal-title":"Gut"},{"key":"327_CR50","first-page":"G920","volume":"273","author":"N Imeryuz","year":"1997","unstructured":"Imeryuz N, Yegen BC, Bozkurt A, Coskun T, Villanueva-Penacarrillo ML, Ulusoy NB: Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol. 1997, 273: G920-G927.","journal-title":"Am J Physiol"},{"key":"327_CR51","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1365-2982.2009.01317.x","volume":"21","author":"V Bucinskaite","year":"2009","unstructured":"Bucinskaite V, Tolessa T, Pedersen J, Rydqvist B, Zerihun L, Holst JJ, Hellstrom PM: Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol Motil. 2009, 21: 978-e978. 10.1111\/j.1365-2982.2009.01317.x.","journal-title":"Neurogastroenterol Motil"},{"key":"327_CR52","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1113\/jphysiol.2009.175067","volume":"587","author":"GM Holmes","year":"2009","unstructured":"Holmes GM, Browning KN, Tong M, Qualls-Creekmore E, Travagli RA: Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions. J Physiol. 2009, 587: 4749-4759. 10.1113\/jphysiol.2009.175067.","journal-title":"J Physiol"},{"key":"327_CR53","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejphar.2013.09.072","volume":"722","author":"PL Andrews","year":"2014","unstructured":"Andrews PL, Sanger GJ: Nausea and the quest for the perfect anti-emetic. Eur J Pharmacol. 2014, 722: 108-121. 10.1016\/j.ejphar.2013.09.072.","journal-title":"Eur J Pharmacol"},{"key":"327_CR54","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/en.2004-0419","volume":"146","author":"JL Lachey","year":"2005","unstructured":"Lachey JL, D'Alessio DA, Rinaman L, Elmquist JK, Drucker DJ, Seeley RJ: The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice. Endocrinology. 2005, 146: 458-462. 10.1210\/en.2004-0419.","journal-title":"Endocrinology"},{"key":"327_CR55","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","volume":"62","author":"SE Kanoski","year":"2012","unstructured":"Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR: The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology. 2012, 62: 1916-1927. 10.1016\/j.neuropharm.2011.12.022.","journal-title":"Neuropharmacology"},{"key":"327_CR56","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00005176-200402000-00025","volume":"38","author":"CA Richards","year":"2004","unstructured":"Richards CA, Andrews PL: Food refusal: a sign of nausea?. J Pediatr Gastroenterol Nutr. 2004, 38: 227-228. 10.1097\/00005176-200402000-00025.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"327_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1365-2982.1997.d01-61.x","volume":"9","author":"BD Kiernan","year":"1997","unstructured":"Kiernan BD, Soykan I, Lin Z, Dale A, McCallum RW: A new nausea model in humans produces mild nausea without electrogastrogram and vasopressin changes. Neurogastroenterol Motil. 1997, 9: 257-263. 10.1046\/j.1365-2982.1997.d01-61.x.","journal-title":"Neurogastroenterol Motil"},{"key":"327_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/1469-8986.00005","volume":"40","author":"PJ Gianaros","year":"2003","unstructured":"Gianaros PJ, Quigley KS, Muth ER, Levine ME, Vasko RC, Stern RM: Relationship between temporal changes in cardiac parasympathetic activity and motion sickness severity. Psychophysiology. 2003, 40: 39-44. 10.1111\/1469-8986.00005.","journal-title":"Psychophysiology"},{"key":"327_CR59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3357\/ASEM.2932.2011","volume":"82","author":"LT LaCount","year":"2011","unstructured":"LaCount LT, Barbieri R, Park K, Kim J, Brown EN, Kuo B, Napadow V: Static and dynamic autonomic response with increasing nausea perception. Aviat Space Environ Med. 2011, 82: 424-433. 10.3357\/ASEM.2932.2011.","journal-title":"Aviat Space Environ Med"},{"key":"327_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3122\/jabfm.18.2.97","volume":"18","author":"JA Kim","year":"2005","unstructured":"Kim JA, Park YG, Cho KH, Hong MH, Han HC, Choi YS, Yoon D: Heart rate variability and obesity indices: emphasis on the response to noise and standing. J Am Board Fam Pract. 2005, 18: 97-103. 10.3122\/jabfm.18.2.97.","journal-title":"J Am Board Fam Pract"},{"key":"327_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0165-1838(97)00090-8","volume":"67","author":"I Doweck","year":"1997","unstructured":"Doweck I, Gordon CR, Shlitner A, Spitzer O, Gonen A, Binah O, Melamed Y, Shupak A: Alterations in R-R variability associated with experimental motion sickness. J Auton Nerv Syst. 1997, 67: 31-37. 10.1016\/S0165-1838(97)00090-8.","journal-title":"J Auton Nerv Syst"},{"key":"327_CR62","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/1469-8986.3730378","volume":"37","author":"GR Morrow","year":"2000","unstructured":"Morrow GR, Andrews PL, Hickok JT, Stern R: Vagal changes following cancer chemotherapy: implications for the development of nausea. Psychophysiology. 2000, 37: 378-384. 10.1111\/1469-8986.3730378.","journal-title":"Psychophysiology"},{"key":"327_CR63","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1523\/JNEUROSCI.22-23-10470.2002","volume":"22","author":"KP Kinzig","year":"2002","unstructured":"Kinzig KP, D'Alessio DA, Seeley RJ: The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci. 2002, 22: 10470-10476.","journal-title":"J Neurosci"},{"key":"327_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/0028-3908(92)90034-M","volume":"31","author":"P Bhandari","year":"1992","unstructured":"Bhandari P, Bingham S, Andrews PL: The neuropharmacology of loperamide-induced emesis in the ferret: the role of the area postrema, vagus, opiate and 5-HT3 receptors. Neuropharmacology. 1992, 31: 735-742. 10.1016\/0028-3908(92)90034-M.","journal-title":"Neuropharmacology"},{"key":"327_CR65","doi-asserted-by":"crossref","first-page":"R1243","DOI":"10.1152\/ajpregu.2001.281.4.R1243","volume":"281","author":"I Billig","year":"2001","unstructured":"Billig I, Yates BJ, Rinaman L: Plasma hormone levels and central c-Fos expression in ferrets after systemic administration of cholecystokinin. Am J Physiol Regul Integr Comp Physiol. 2001, 281: R1243-R1255.","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-014-0327-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0327-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0327-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:09:16Z","timestamp":1747181356000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-014-0327-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1186\/s12967-014-0327-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"23 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"327"}}